Literature DB >> 25608280

Evaluation of the accuracy of grading indirect ophthalmoscopy video images for retinopathy of prematurity screening.

Sasapin G Prakalapakorn, David K Wallace, Riana S Dolland, Sharon F Freedman.   

Abstract

PURPOSE: To determine whether digital retinal images obtained using a video indirect ophthalmoscopy system can be accurately graded for zone, stage of retinopathy of prematurity (ROP), and plus or pre-plus disease, and used to screen for type 1 ROP.
METHODS: Charts of 114 infants who had retinal video images acquired using the video indirect ophthalmoscopy system during routine ROP examinations were retrospectively reviewed. Two masked ophthalmologists (1 expert and 1 non-expert in ROP screening) graded the video images for image quality, zone, stage of ROP, and pre-plus or plus disease. The ophthalmologists' grades of the videos were compared to the clinical examination results, which served as the reference standard. The sensitivity and specificity of two predefined criteria for referral in detecting disease requiring treatment (ie, type 1 ROP) were then determined.
RESULTS: Of images the expert considered fair or good quality (n = 68), the expert and non-expert correctly identified zone (75% vs 74% of images, respectively), stage of ROP (75% vs 40% of images, respectively), and the presence of pre-plus or plus disease (79% of images). Expert and non-expert judgment of pre-threshold disease, pre-plus disease, or plus disease had 100% sensitivity and 75% versus 79% specificity, respectively, for detecting type 1 ROP. Expert and non-expert judgment of pre-plus or plus disease had 92% versus 100% sensitivity and 77% versus 82% specificity, respectively, for detecting type 1 ROP.
CONCLUSIONS: High-quality retinal video images can be read with high sensitivity and acceptable specificity to screen for type 1 ROP. Grading for pre-plus or plus disease alone may be sufficient for the purpose of ROP screening. Copyright 2015, SLACK Incorporated.

Entities:  

Mesh:

Year:  2015        PMID: 25608280      PMCID: PMC4411041          DOI: 10.3928/01913913-20150114-02

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  11 in total

Review 1.  The International Classification of Retinopathy of Prematurity revisited.

Authors: 
Journal:  Arch Ophthalmol       Date:  2005-07

2.  Screening examination of premature infants for retinopathy of prematurity.

Authors: 
Journal:  Pediatrics       Date:  2006-02       Impact factor: 7.124

3.  Standard image of plus disease in retinopathy of prematurity.

Authors:  Antonio Capone; Anna L Ells; Alistair R Fielder; John T Flynn; Glen A Gole; William V Good; Jonathan M Holmes; Gerd Holmstrom; Ximena Katz; J Arch McNamara; Earl A Palmer; Graham E Quinn; Michael Shapiro; Michael G J Trese; David K Wallace
Journal:  Arch Ophthalmol       Date:  2006-11

4.  Telemedicine screening for retinopathy of prematurity in developing countries using digital retinal images: a feasibility project.

Authors:  Alison H Skalet; Graham E Quinn; Gui-Shuang Ying; Luz Gordillo; Luz Dodobara; Ken Cocker; Alistair R Fielder; Anna L Ells; Monte D Mills; Clare Wilson; Clare Gilbert
Journal:  J AAPOS       Date:  2008-03-04       Impact factor: 1.220

5.  Evaluation of an indirect ophthalmoscopy digital photographic system as a retinopathy of prematurity screening tool.

Authors:  Sasapin G Prakalapakorn; Sharon F Freedman; David K Wallace
Journal:  J AAPOS       Date:  2014-02       Impact factor: 1.220

6.  Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1988-04

7.  An update on progress and the changing epidemiology of causes of childhood blindness worldwide.

Authors:  Lingkun Kong; Melinda Fry; Mohannad Al-Samarraie; Clare Gilbert; Paul G Steinkuller
Journal:  J AAPOS       Date:  2012-12       Impact factor: 1.220

8.  Neonatologists' practices and experiences in arranging retinopathy of prematurity screening services.

Authors:  Alex R Kemper; David K Wallace
Journal:  Pediatrics       Date:  2007-09       Impact factor: 7.124

9.  Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

Authors: 
Journal:  Arch Ophthalmol       Date:  2003-12

Review 10.  Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control.

Authors:  Clare Gilbert
Journal:  Early Hum Dev       Date:  2008-01-29       Impact factor: 2.079

View more
  5 in total

1.  Facilitated Versus Self-guided Training of Non-ophthalmologists for Grading Pre-plus and Plus Disease Using Fundus Images for Retinopathy of Prematurity Screening.

Authors:  Nikolas N Raufi; Caleb K Morris; Sharon F Freedman; David K Wallace; S Grace Prakalapakorn
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2016-05-01       Impact factor: 1.402

2.  East of England regional retinopathy of prematurity service: lessons from the first year.

Authors:  L E Allen; A Te Water Naudé
Journal:  Eye (Lond)       Date:  2018-01-19       Impact factor: 3.775

3.  Posterior Pole Vascular Changes Before Treatment of Retinopathy of Prematurity.

Authors:  S Grace Prakalapakorn; David K Wallace; Sharon F Freedman
Journal:  JAMA Ophthalmol       Date:  2017-12-01       Impact factor: 7.389

4.  Evaluating a Portable, Noncontact Fundus Camera for Retinopathy of Prematurity Screening by Nonophthalmologist Health Care Workers.

Authors:  S Grace Prakalapakorn; Sharon F Freedman; Amy K Hutchinson; David K Wallace; Sandra S Stinnett; J Wayne Riggins; Keith J Gallaher
Journal:  Ophthalmol Retina       Date:  2018-01-10

5.  Key factors in a rigorous longitudinal image-based assessment of retinopathy of prematurity.

Authors:  Tatiana R Rosenblatt; Marco H Ji; Daniel Vail; Cassie A Ludwig; Ahmad Al-Moujahed; Malini Veerappan Pasricha; Natalia F Callaway; Jochen Kumm; Darius M Moshfeghi
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.